Advertisement
Screener

Clene Inc. (CLNN) Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

2.8 / 5 stars · 68/120 Roast Me

Clene Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

Clene Inc. (CLNN) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $8.47 million as of 2025-12-31, per its 10-K filed 2026-03-17.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-17

  • 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $8.47M.
  • 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $7.37M.
  • 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $6.04M.
  • 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.85M.
Period endDeferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
2025-12-31$8.47M
10-K · filed 2026-03-17
2024-12-31$7.37M
10-K · filed 2026-03-17
2023-12-31$6.04M
10-K · filed 2025-03-24
2022-12-31$3.85M
10-K · filed 2024-03-13
2021-12-31$2.81M
10-K · filed 2023-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
Xilio Therapeutics, Inc. (XLO)United States$0.052B
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
TALPHERA, INC. (TLPH)United States$0.060B